President Trump has sworn in ex-pharma industry executive Alex Azar as his new Health Secretary – and says tackling drug prices and the opioid crisis will be among his top priorities.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh